Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionHiroki Watanabe, Neiko Ozasa, Takeshi Morimoto et al.|PLoS ONE|2018Cited by 128
Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable PolymerMasahiro Natsuaki, Takeshi Kimura, Tetsuya Ishikawa et al.|Circulation Cardiovascular Interventions|2015Cited by 64
Rare variants in <i>RNF213</i>, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia‐induced pulmonary hypertension in miceHatasu Kobayashi, Akio Koizumi, Risako Kabata et al.|Pulmonary Circulation|2018Cited by 48
Intravascular Ultrasound Guidance vs. Angiographic Guidance in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction – Long-Term Clinical Outcomes From the CREDO-Kyoto AMI Registry –Kenji Nakatsuma, Hiroki Shiomi, Takeshi Morimoto et al.|Circulation Journal|2015Cited by 43
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New‐Generation Drug‐Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT TrialsHiroki Watanabe, Takeshi Morimoto, Hiroki Shiomi et al.|Journal of the American Heart Association|2018Cited by 25